Infinata’s BioPharm Insight Releases its Catalyst Monitor for March…

Key catalysts include US approval decisions for Zogenix, Biogen Idec, and Johnson & Johnson.

(PRWeb February 26, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10466568.htm


Comments are closed.